1. Immunoassay for quantifying type I collagen degradation products in urine evaluated;Bonde;Clin Chem,1994
2. Hormone replacement therapy in postmenopausal women;Chesnut;Am J Med,1997
3. Matrix delivery transdermal 17 β estradiol for the prevention of bone loss in postmenopausal women;Cooper;Osteoporos Int,1999
4. Delmas, P. D. and Garnero, P. Utility of biochemical markers of bone turnover in osteoporosis. In: Marcus, R., Feldman, D., and Keysel, J., Eds. Osteoporosis. San Diego: Academic Press; 1075–1085; 1996.
5. Delmas, P. D. and Garnero, P. Biological markers of bone turnover in osteoporosis. In: Stevenson, J. C., Lindsay, R., Eds. Osteoporosis. London: Chapman and Hall; 117–136; 1998.